723
Views
3
CrossRef citations to date
0
Altmetric
Letter to the Editor

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

, , , , , ORCID Icon, ORCID Icon, , , , , , , , , , , & ORCID Icon show all
Pages 1981-1985 | Received 27 Jun 2017, Accepted 31 Oct 2017, Published online: 08 Jan 2018
 

Acknowledgments

This study was supported by research funding from Olink Bioscience, Uppsala, Sweden to O.L., and also was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1403020.

Additional information

Funding

This study was supported by research funding from Olink Bioscience, Uppsala, Sweden to O.L., and also was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.